Ajmal Hussain

Ajmal Hussain

Software & Internet Analyst

Software and internet analyst focused on SaaS, platform businesses, and AI application layers. Former growth analyst with experience in ARR modeling, churn/NRR analysis, and competitive positioning. Writes with a product-first lens: why users adopt, why they stay, and what drives pricing power.

Articles 743

Jan 8, 2026 Finance

Paul Krugman Challenges Economic Justification of U.S. Actions in Venezuela: 'A Battle Over Illusory Oil Wealth'

Nobel Laureate Contends That Venezuela's Vast Oil Reserves Are More Fiction Than Fact, Casting Doubt on the Financial Motive Behind Recent Political Moves

Economist Paul Krugman questions the economic foundation of U.S. involvement in Venezuela, emphasizing that the purported oil riches are largely mythi...

US Withdraws from Multiple Global Organizations Undermining International Cooperation
Jan 7, 2026 News & Politics

US Withdraws from Multiple Global Organizations Undermining International Cooperation

The administration halts support for 66 international agencies including key UN bodies, reshaping America’s global partnership strategy

The United States government has enacted a significant policy shift by pulling out from 66 international organizations, mainly those associated with t...

Jan 7, 2026 Trade Ideas

Bright Minds (DRUG) - Breakthrough Readout Reprices a Binary Biotech; Buy the Breakout for a Swing Win

Top-line clinical breakthrough (market-moving) plus clear pathway to partnering supports a 'Strong Buy' trade — tactical entry, disciplined stop, asymmetric upside.

Bright Minds Biosciences reported market-moving breakthrough clinical data and the stock has ripped higher — trading near $96 as of 01/07/2026. The ...

Trade Idea Long
Jan 7, 2026 Finance

Lockheed Martin Shares Decline Following Presidential Call for Defense Industry Investment Shift

President Advocates Halting Buybacks and Dividends Until Production and Maintenance Improve

Lockheed Martin’s stock experienced a significant drop after President Donald Trump publicly criticized defense contractors for prioritizing shareho...

New York City Mayor Supports Housing Chief Amid Controversy Over Past Social Media Posts
Jan 7, 2026 News & Politics

New York City Mayor Supports Housing Chief Amid Controversy Over Past Social Media Posts

Zohran Mamdani defends tenant protection leader Cea Weaver despite criticism over her previous online statements

New York City Mayor Zohran Mamdani has publicly backed Cea Weaver, the newly appointed executive director of the Mayor’s Office to Protect Tenants, ...

Jan 7, 2026 Finance

ETF Trading Activity in Bitcoin, Ethereum, and Solana Drives Notable Crypto Market Momentum in Early 2026

Institutional ETF volumes indicate evolving investor confidence across key cryptocurrencies at the start of the year

The early months of 2026 have witnessed significant increases in Exchange-Traded Fund (ETF) trading volumes tied to Bitcoin, Ethereum, and Solana. Thi...

Jan 7, 2026 Finance

Compass Inc Shares Surge Following Convertible Notes Offering Announcement

Convertible Senior Notes Offering Spurs Volatility but Drives Stock to Yearly High

Compass Inc announced a $750 million private placement of convertible senior notes due 2031, initially causing a dip in trading due to dilution concer...

Ripple Rejects IPO Route After $500M Capital Raise, Prioritizes Private Expansion
Jan 7, 2026 Finance

Ripple Rejects IPO Route After $500M Capital Raise, Prioritizes Private Expansion

Opting for acquisitions and product innovation, Ripple pursues private growth over public market entry

Ripple has decided against pursuing an initial public offering (IPO) despite securing $500 million in funding at a $40 billion valuation. The company'...

Jan 7, 2026 Finance

Microsoft and Hexagon Collaborate to Advance AI-Driven Humanoid Robots in Industrial Settings

Partnership targets innovative automation solutions for sectors facing labor shortages and operational challenges

Microsoft Corporation and Hexagon Robotics have announced a strategic partnership aimed at developing adaptive humanoid robots for manufacturing and i...

Jan 7, 2026 Finance

GSK and Ionis Announce Positive Phase 3 Results for Investigational Hepatitis B Treatment Bepirovirsen

Bepirovirsen demonstrates significant functional cure rates in chronic hepatitis B patients, advancing toward regulatory submission

GSK and Ionis Pharmaceuticals reported encouraging outcomes from two large-scale Phase 3 clinical trials evaluating bepirovirsen, an investigational a...